Log in to save to my catalogue

1095 Management of paclitaxel associated hypersensitivity reactions in gynecological cancers: a sing...

1095 Management of paclitaxel associated hypersensitivity reactions in gynecological cancers: a sing...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2955870814

1095 Management of paclitaxel associated hypersensitivity reactions in gynecological cancers: a single center retrospective analysis

About this item

Full title

1095 Management of paclitaxel associated hypersensitivity reactions in gynecological cancers: a single center retrospective analysis

Publisher

Kidlington: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A275-A275

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Introduction/BackgroundIn the treatment of gynecological tumors, taxanes currently represent the main chemotherapeutic drugs to be used in clinical practice. A minority of patients experience allergic reactions limiting the possibilities for oncological treatment (1–10%). Several desensitization protocols were proposed to overcome the hypersensitiv...

Alternative Titles

Full title

1095 Management of paclitaxel associated hypersensitivity reactions in gynecological cancers: a single center retrospective analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2955870814

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2955870814

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2024-ESGO.535

How to access this item